<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>28196580</identifier>
<setSpec>1578-8989</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Yerovi, Estefanía</dc:author>
<dc:author>Caravaca-Fontán, Fernando</dc:author>
<dc:author>Galeano, Cristina</dc:author>
<dc:author>Delgado-Yagu E, María</dc:author>
<dc:author>Tenorio, Maria Teresa</dc:author>
<dc:author>Liaño, Fernando</dc:author>
<dc:author>Pampa-Saico, Saúl</dc:author>
<dc:description xml:lang="en">INTRODUCTION The anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis with renal involvement are associated with high morbi-mortality. In this study we analyse if the prognosis of these diseases have improved in recent years, and which factors influence the outcomes. MATERIAL AND METHODS Retrospective single-centre observational study, which included all patients diagnosed with microscopic polyangiitis and granulomatosis with polyangiitis with renal involvement in the last 25 years. Demographic, clinical and biochemical parameters of prognostic interest were recorded. The differences between four chronological periods were analysed, along with the determinants of a poor outcome (death or end-stage renal disease). RESULTS Eighty-nine patients were included (mean age 64±15 years). Sixty-four patients (72%) had microscopic polyangiitis and 25 (28%) granulomatosis with polyangiitis. During the study period, 37 (42%) patients died. Through Cox regression analysis, the best determinants of mortality were the initial glomerular filtration rate (HR 0.911; P=.003), Charlson comorbidity index (HR 1.513; P&lt;.0001) and tobacco smoking (HR 1.816; P=.003). 35% developed end-stage renal disease, and the best determinants (by competing-risk regression) were: initial glomerular filtration rate (sub-hazard ratio [SHR]: 0.791; P&lt;.0001), proteinuria (SHR: 1.313; P&lt;.0001), and smoking status (SHR: 1.848; P=.023). No differences were found in patients' mortality or renal survival between the different study periods. CONCLUSIONS Prognosis of anti-neutrophil cytoplasm antibodies vasculitis with renal involvement treated with conventional immunosuppressive therapy remains unsatisfactory, and continues to have increased long-term complications and mortality.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Microscopic polyangiitis</dc:subject>
<dc:subject>Anti-neutrophil cytoplasm antibodies</dc:subject>
<dc:subject>Anticuerpos contra el citoplasma de neutrófilo</dc:subject>
<dc:subject>Mortality</dc:subject>
<dc:subject>Granulomatosis con poliangitis</dc:subject>
<dc:subject>Renal vasculitis</dc:subject>
<dc:subject>Granulomatosis with polyangiitis</dc:subject>
<dc:subject>Mortalidad</dc:subject>
<dc:subject>Poliangitis microscópica</dc:subject>
<dc:subject>Vasculitis renal</dc:subject>
<dc:date>2017 Jan 06 </dc:date>
<dc:title xml:lang="es">Vasculitis asociada a anticuerpos contra el citoplasma de neutrófilo con afectación renal: análisis de 89 casos.</dc:title>
<dc:title xml:lang="en">Anti-neutrophil cytoplasmic antibody-associated vasculitis with renal involvement: Analysis of 89 cases.</dc:title>
<dc:publisher>Medicina clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
